Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0P9KD
|
|||
Former ID |
DND000008
|
|||
Drug Name |
PF-3732010
|
|||
Synonyms |
P-cadherin MAb, PF-03072010, PF-03732010
Click to Show/Hide
|
|||
Drug Type |
Antibody
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 1 | [1] | |
Company |
Pfizer
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Placental cadherin (CDH3) | Target Info | . | [2] |
KEGG Pathway | Cell adhesion molecules (CAMs) | |||
Panther Pathway | Alzheimer disease-presenilin pathway | |||
Cadherin signaling pathway | ||||
Wnt signaling pathway | ||||
Reactome | Adherens junctions interactions | |||
WikiPathways | Hair Follicle Development: Induction (Part 1 of 3) | |||
Cell junction organization |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT00557505) A Study Of PF-03732010 In Patients With Advanced Solid Tumors. U.S. National Institutes of Health. | |||
REF 2 | National Cancer Institute Drug Dictionary (drug id 580366). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.